Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 6 minute read Pharma Industry News Merck (NASDAQ: MRK) wins FDA approval for ENFLONSIA to prevent RSV in infants FDA clears Merck’s ENFLONSIA (NASDAQ: MRK) for RSV prevention in infants. See trial data, stock reaction, pediatric market impact & analyst projections. bySoujanya RaviJune 9, 2025